Supreme Court Shields Bayer From Roundup Cancer Warning Lawsuits
The Supreme Court ruled 7-2 that federal law preempts state-level lawsuits against Bayer for omitting cancer warnings on Roundup herbicide labels.
The Supreme Court of the United States ruled 7-2 that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law failure-to-warn claims against Bayer, the parent company of Monsanto. Writing for the majority, Justice Brett Kavanaugh concluded that because the Environmental Protection Agency (EPA) determined a cancer warning was not necessary for Roundup, companies cannot be penalized under state tort laws for complying with federal labeling requirements. The ruling overturned a $1.25 million jury verdict awarded to Missouri resident John Durnell, who developed non-Hodgkin lymphoma.
Bayer CEO Bill Anderson stated the decision brings "overdue justice" and provides regulatory clarity, causing the company's shares to surge nearly 18 percent. While the ruling blocks failure-to-warn claims, plaintiffs may still pursue cases based on product design or negligence. The decision was supported by the Trump administration, which also issued an executive order to increase domestic glyphosate production.
The verdict sparked significant backlash from the "Make America Healthy Again" (MAHA) movement, with activists accusing the Republican Party of prioritizing corporate interests over public health. In response to the friction, the EPA announced a comprehensive scientific review of glyphosate to be completed by October 1, 2026. Additionally, Representative Anna Paulina Luna announced plans to introduce legislation stripping pesticide companies of liability protections, arguing that such firms purposefully omit health risks.